Strand Therapeutics Stock
HealthTechLooking to sell Strand Therapeutics stock or options?
Strand Therapeutics delivers biotechnology services aimed at developing gene therapies through synthetic biology. The company's services focus on crafting immunotherapies that produce specific cancer-targeting proteins during treatment, allowing patients to enhance their immune response to combat cancer effectively.
ATMA Capital, BeiGene, FPV Ventures, Creative Destruction Lab, Redmile Group, Potentum Partners, Johnson & Johnson Innovation - JLABS, JIC Venture Growth Investments, DHVC, Eli Lilly and Company Foundation, Playground Global, Camford Capital, National Institutes of Health, Starlight Ventures, Alexandria Venture Investments, Massachusetts Institute of Technology Endowment, Endless Frontier Labs, ANRI, MassChallenge, Eli Lilly and Company.